Basic Information
The company collaborates with Arvinas on protein degradation therapy. AstraZeneca sells four mature products to ANI, while Summit enhances its antibiotic capabilities through the buyout of Discuva and grants Latin American rights to ridinilazole.
HanX Biopharmaceuticals Inc.
--
unclear
--
--
--